Bruno Paiva: EHA 2025 CTC Session in Myeloma and Amyloidosis Bruno Paiva, Director Flow Cytometry Core – CIMA LAB Diagnostics, posted on X: “EHA 2025 CTC session in myeloma and amyloidosis. CTCs are fighting for a sit on the table of routine staging of these patients.” More posts featuring EHA 2025. Blog Posts amyloidosis multiple myeloma Bruno Paiva cancer EHA2025 OncoDaily Oncology